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Abstract 
The possibility of creating of a monochromatic gamma emitter of low energy quanta is 
analyzed. The idea is based on Daning’s scheme. Except for purely scientific problems 
the monochromator is actual for therapy of wide range of diseases. 
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1. Introduction 
 
A great number of applications of nuclear physical methods were realized with 
applications based on the monochromators of neutrons. 
Here the possibility of creating a monochromatic gamma emitter of low energy quanta is 
analyzed. Except for purely scientific problems that monochromator is actual for therapy 
of wide range of diseases [1].  
The monochromator suggested includes monochromator of neutrons, and the well-known 
scheme of Daning[2] is used. 
The flight-method is known in the neutron spectroscopy: 
The neutrons with fixed velocities are separated by using the difference in their flight 
time along the distance source -detector. For that purpose mechanical devices called 
mechanical selectors of neutrons are set on the way of the neutron flow. 
In 1935 Daning built a monochromator with helical shape like slits. [2]. The modern 
mechanical monochromators for thermal and intermediate-energy (1 – 1.10 4[eV]) 
neutrons are based on the same principle. They contain a cylinder with curvilinear slits, 
longitudinal or cross to its axis of rotation. The rotаtor surface may contain a lot of 
helical slits so that the system outlet produces uninterrupted beam of monoenergetic 
neutrons. The energy resolution of the instrument depends on the rotator length, the 
angular speed of rotation and the width of its slits. 
Namely, an instrument of that kind can be used for the excitation of a reaction(n,γ) of 
radiative capture of neutrons in layers from resonant absorbing materials: the energy of 
the excited nucleus is emitted in gamma quanta. Two boundary cases are possible: the 
final nucleus is a stable isotope of the irradiated one; the final nucleus is radioactive – the 
product are radioactive isotopes. 
 
2. Principle and scheme realization of monochromatic gamma emitter for low energy 
quanta 
The figures 1, 2, and 3 present the cross sections for radiative capture (green color) and 
the total cross section of Se-76, Fe-56 and Ni-60 (red color) vs  the striking neutrons 
energy.  
Plots are received from the internet site of Korea Atomic Energy Research 
Institute(KAERI)[3]. 
For Fe-56 and Ni-60 data from ENDF/B-6.1 [4], when for Se-76-from ENDF/B-VІ, 
release 8 [5] is used. 
Also, isotopes Cr-52, Ca-43, Fe-57, Mo-94, Nd-142, Sr-86, Xe-128, Xe-130, He-3 have 
similar properties. 
The plots suggest that for certain energies of the initial neutron beam the process of 
radiative capture is resonant and the other possible processes are negligible.  
The value of the energy, corresponding to the resonance maximum allows the calculation 
of the wavelength of the emitted monochromatic wave λ. 
Our calculations show that for energies within the interval 10 3-10 5 [eV] the emission is 
in the range of wavelengths typical for X- and gamma emission. 
Furthermore, because of the resonant character of the reaction, X- and gamma emission is 
resonant and monochromatic with line width of the order of 0.2-0.3[eV] [2]. 
In addition, both initial and final products of the reaction are stable isotopes. 
Fig. 4 illustrates a principle scheme of monochromatic gamma emitter based on the 
arguments discussed above. 
It consists of:  
1. a source of neutrons of intermediate energies; 
2. fast mechanical separator tuned to the interval of energies characteristic for the next 
element–3 resonant absorption region.  
3. layer absorbing neutrons of defined energy emitted from the element 2. 
4. nozzle of truncated cone shape (for example from steel) collimating the light beam 
5. protecting shell 
In our opinion the suggested scheme should emit strictly monochromatic gamma quanta 
of low energies. 
Therefore, a possible application of the scheme seems to be in the medicine for treatment 
of the diseases described in table 1[1], as well as for radiation therapy for some kinds of 
cancer [6,7,8,9,10,11,12,13,14]. 
For that purpose element 6 can be added to the elements from the fig. 4. 
It represents cylindrical tube (for example from steel), which fixes the acted area size and 
by the element 6a chops the outgoing ray from element 4 to great number of lower 
intensity rays. 
The same procedure is used in the therapeutical method Intensity Modulated Radiation 
Therapy (IMRT)[15], realized by the Nomos Corporation. 
Distinctive marks of the proposed scheme are comparatively low energy of the outlet 
beam and the possibility to vary its diameter and emission energy. 
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Table 1[1] 
Ameloblastoma 
Aneurysmal bone cyst 
Angiofibroma 
Arteriovenous malformation 
Chemodectoma 
Chordoma 
Craniopharyngioma 
Desmoid tumor 
Graves' ophthalmopathy 
Gynecomastia associated with hormonal management of prostate cancer 
Hemangioma 
Heterotopic bone formation 
Hypersplenism 
Keloid 
Keratoacanthoma 
Meningioma 
Peyronie's disease 
Pituitary adenoma 
Pterygium 
Total lymphoid irradiation for autoimmune disease or organ transplantation 
Vascular restenosis prevention 
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